Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case
Competition & Consumer Protection 2018-02-28 3:47 pmBy Christine Caulfield | Melbourne
Please login to bookmark Close

Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au